tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Olema Oncology price target lowered to $38 from $40 at Guggenheim
PremiumThe FlyOlema Oncology price target lowered to $38 from $40 at Guggenheim
3d ago
Roche deploying more than 3,500 Nvidia Blackwell GPUs
Premium
The Fly
Roche deploying more than 3,500 Nvidia Blackwell GPUs
3d ago
Roche price target lowered to CHF 365 from CHF 385 at HSBC
Premium
The Fly
Roche price target lowered to CHF 365 from CHF 385 at HSBC
3d ago
Roche price target lowered to CHF 325 from CHF 350 at JPMorgan
PremiumThe FlyRoche price target lowered to CHF 325 from CHF 350 at JPMorgan
8d ago
Xencor reports receipt of notice of termination of license agreement from Roche
Premium
The Fly
Xencor reports receipt of notice of termination of license agreement from Roche
11d ago
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
Premium
The Fly
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
11d ago
Genentech reports Phase 2 ZUPREME-1 weight loss trial met primary endpoint
PremiumThe FlyGenentech reports Phase 2 ZUPREME-1 weight loss trial met primary endpoint
15d ago
Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating
Premium
Ratings
Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating
18d ago
Genentech announces fenebrutinib study met primary endpoint
Premium
The Fly
Genentech announces fenebrutinib study met primary endpoint
18d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100